Send mail to Author
Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderate-to-severe psoriasis through 2 years of treatment : results from the CLEAR study (Article)Please indicate your contact information and select, which author you want to contact.